https://www.selleckchem.com/pr....oducts/JNJ-7706621.h
ng among many with poor outcomes indicates possible opportunities for implementation of decision support. Follow up after AKI has potential net-benefit for pre-empting readmissions, death and subsequent CKD progression. Decisions could be improved by using risk models and by focusing on AKI across a full spectrum of severity. The current lack of monitoring among many with poor outcomes indicates possible opportunities for implementation of decision support.The current outbreak of novel COVID-19 challenges the development of an effic